Newly discovered protein kinase shows promise for establishing future obesity and diabetes treatments

Researchers used genetically modified animal models to investigate the role of the newly discovered Traf2- and NCK-interacting protein kinase (TNIK) in obesity and metabolic dysfunction.

After approvals for one of cancer’s ‘undruggable’ targets, research into new KRAS therapies booms: #AACR24

For cancer researchers, the potential was as obvious as the problem. Mutations to the KRAS gene drive nearly a third of all cancers. A laundry

April 12, 2024

Integrated care may not be the silver bullet for mental health treatment, study finds

Health care systems in the United States have gradually embraced the concept that mental health should be treated on par with physical health, especially in

December 29, 2023

The DNA from dog tumors may hold the secret to better human cancer drugs

This year, nearly 6 million dogs in the U.S. will receive a cancer diagnosis. That’s approximately three times greater than the number of Americans who

June 16, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.